pmid
stringclasses
42 values
meta_analysis_title
stringclasses
42 values
meta_analysis_question
stringclasses
42 values
criteria
stringclasses
42 values
subgroup
stringclasses
242 values
key_reference_title
stringclasses
922 values
key_reference_abstract
stringclasses
921 values
truth
stringclasses
2 values
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
A pilot study of an Internet walking program and pedometer in COPD.
## BACKGROUND Higher levels of physical activity are associated with better functional status, fewer hospital admissions, and lower mortality. In this pilot study, we examined the feasibility and safety of a novel program that combines a pedometer with a website to increase walking. ## METHODS 27 persons with stable CO...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Pilot study of a cell phone-based exercise persistence intervention post-rehabilitation for COPD.
## OBJECTIVE To determine the feasibility and efficacy of a six-month, cell phone-based exercise persistence intervention for patients with chronic obstructive pulmonary disease (COPD) following pulmonary rehabilitation. ## METHODS Participants who completed a two-week run-in were randomly assigned to either MOBILE-Coa...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Effect of Physical Activity Coaching on Acute Care and Survival Among Patients With Chronic Obstructive Pulmonary Disease: A Pragmatic Randomized Clinical Trial.
## IMPORTANCE While observational studies show that physical inactivity is associated with worse outcomes in chronic obstructive pulmonary disease (COPD), there are no population-based trials to date testing the effectiveness of physical activity (PA) interventions to reduce acute care use or improve survival. ## OBJEC...
True
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Pedometer Step Count Targets during Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
## RATIONALE Increasing physical activity is a key therapeutic aim in chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation (PR) improves exercise capacity, but there is conflicting evidence regarding its ability to improve physical activity levels. ## OBJECTIVES To determine whether using pedometers a...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Evaluating the effect of a smartphone app-based self-management program for people with COPD: A randomized controlled trial.
## AIM To examine the effect of a 6-month, smartphone app-based self-management program for people with chronic obstructive pulmonary disease (COPD). ## BACKGROUND Technological interventions have been used for chronic disease management, but the effect of a self-management program using a smartphone app has not been e...
True
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
A randomised trial of a web-based physical activity self-management intervention in COPD.
Improving exercise capacity is a primary objective in COPD. Declines in exercise capacity result in reduced physical activity and health-related quality of life (HRQoL). Self-management interventions can teach patients skills and behaviours to manage their disease. Technology-mediated interventions have the potential t...
True
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Using a smartphone application maintains physical activity following pulmonary rehabilitation in patients with COPD: a randomised controlled trial.
## BACKGROUND Evidence suggests that patients with COPD struggle to maintain improved physical activity (PA) after completing pulmonary rehabilitation (PR). Smartphone applications (apps) providing a comprehensive training programme have conferred healthy benefits. This study was conducted to determine whether regular ...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Effects of individualized target setting on step count in Japanese patients with chronic obstructive pulmonary disease: a pilot study.
## INTRODUCTION Improving physical activity in patients with chronic obstructive pulmonary disease (COPD) is a very important issue; however, effective recommended targets for individual patients remain to be determined. ## MATERIAL AND METHODS We developed a method for setting a target value for the step count for eac...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Promotion of physical activity after hospitalization for COPD exacerbation: A randomized control trial.
## BACKGROUND AND OBJECTIVE Physical activity worsens during exacerbations of chronic obstructive pulmonary disease (COPD) and notably after hospitalizations. Pedometer-based interventions are useful to increase physical activity in stable patients with COPD. However, there is little information concerning the implemen...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Effectiveness of a community-based exercise training programme to increase physical activity level in patients with chronic obstructive pulmonary disease: A randomized controlled trial.
## BACKGROUND AND PURPOSE The exercise training included in pulmonary rehabilitation (PR) programmes improves exercise capacity and quality of life in patients with chronic obstructive pulmonary disease (COPD). Nevertheless, the duration of these effects is limited, and the implementation of PR is still insufficient. M...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Efficacy of an mHealth intervention to stimulate physical activity in COPD patients after pulmonary rehabilitation.
Physical inactivity in patients with chronic obstructive pulmonary disease (COPD) is associated with poor health status and increased disease burden. The present study aims to test the efficacy of a previously developed mobile (m)Health intervention to improve or maintain physical activity in patients with COPD after p...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Promoting physical activity in COPD: Insights from a randomized trial of a web-based intervention and pedometer use.
## RATIONALE Low physical activity is highly prevalent among COPD patients and is associated with increased healthcare utilization and mortality and reduced HRQL. The addition of a website to pedometer use is effective at increasing physical activity; however, the timeline of change and impact of environmental factors ...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations.
## BACKGROUND Technology-based physical activity (PA) interventions have been shown to improve daily step counts and health-related quality of life, but their effect on long-term clinical outcomes like acute exacerbations (AEs) is unknown in persons with COPD. ## METHODS U.S. Veterans with stable COPD were randomized (...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Benefits and costs of home pedometer assisted physical activity in patients with COPD. A preliminary randomized controlled trial.
## BACKGROUND AND OBJECTIVE There are barriers to providing pulmonary rehabilitation for chronic obstructive pulmonary disease (COPD) such as the high number of patients, difficult access to health facilities and high costs of programs. Pedometers can monitor and improve physical activity (PA). The aim of this study wa...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Effect on health-related quality of life of ongoing feedback during a 12-month maintenance walking programme in patients with COPD: a randomized controlled trial.
## BACKGROUND AND OBJECTIVE In patients with COPD, this study evaluated the effect on health-related quality of life (HRQoL) of adding ongoing feedback to a 12-month unsupervised maintenance walking programme. ## METHODS Participants were randomized to either an intervention group (IG) or control group (CG). Both group...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Effects of Ongoing Feedback During a 12-Month Maintenance Walking Program on Daily Physical Activity in People with COPD.
This multi-centred, randomised controlled trial explored the effects of adding ongoing feedback to a 12-month unsupervised maintenance walking program, on daily physical activity (PA) in people with chronic obstructive pulmonary disease. Participants were randomised to either an intervention group (IG) or a usual care ...
False
38012218
Wearable technology interventions in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Do wearable technology interventions improve physical activity, exercise capacity, exacerbation detection, and quality of life in patients with chronic obstructive pulmonary disease (COPD)?
This systematic review and meta-analysis was conducted in accordance with the Preferred Reporting in Systematic Reviews and Meta-Analysis (PRISMA) guidelines and was prospectively registered on PROSPERO (registration number: CRD42022299706).
Meta-analysis investigating the association between wearable technology and COPD exacerbations. - Wearable Tech
Acute Exacerbation of a Chronic Obstructive Pulmonary Disease Prediction System Using Wearable Device Data, Machine Learning, and Deep Learning: Development and Cohort Study.
## BACKGROUND The World Health Organization has projected that by 2030, chronic obstructive pulmonary disease (COPD) will be the third-leading cause of mortality and the seventh-leading cause of morbidity worldwide. Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are associated with an accelerated...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
Rationale: Extremely preterm infants with evolving bronchopulmonary dysplasia (BPD) are at risk for development of BPD-associated pulmonary hypertension (BPD-PH). A patent ductus arteriosus (PDA) shunt may be a modifiable risk factor for BPD-PH development. Objective: To determine whether the presence and duration of d...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
## BACKGROUND The aim of the study was to determine whether prolonged exposure to a moderate/large patent ductus arteriosus left-to-right shunt (PDA) increases the risk of late (beyond 36 weeks) pulmonary hypertension (BPD-PH) and pulmonary vascular disease (BPD-PVD) during the neonatal hospitalization in preterm infan...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children.
## INTRODUCTION Infants with bronchopulmonary dysplasia (BPD) are at high risk of developing cardiovascular sequelae in the form of pulmonary hypertension (PH) which significantly increases morbidity and mortality. The aim of this study was to evaluate the incidence of BPD, to identify characteristics associated with B...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## BACKGROUND AND OBJECTIVES With the increasing survival of preterm infants, pulmonary hypertension (PH) related to bronchopulmonary dysplasia (BPD) has become an important complication. The aim of this study was to investigate the characteristics and outcome of PH in preterm infants with BPD and to identify the risk ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation.
## OBJECTIVES Pulmonary hypertension (PH) is a complication of bronchopulmonary dysplasia (BPD) and associated with increased mortality and morbidity. Our aim was to identify, in infants with BPD, the effect of PH on health-care utilisation and health related cost of care. ## METHODS An electronic data recording system...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Oxygen requirement as a screening tool for the detection of late pulmonary hypertension in extremely low birth weight infants.
## BACKGROUND Many extremely low birth weight infants develop pulmonary hypertension late in their clinical course, and over 60% go undetected by early screening echocardiography. At present, no standardised screening protocol exists for detecting late pulmonary hypertension in extremely low birth weight infants. We as...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Prospective analysis of pulmonary hypertension in extremely low birth weight infants.
## OBJECTIVES Pulmonary hypertension is associated with bronchopulmonary dysplasia in extremely low birth weight (ELBW) infants and contributes to morbidity and mortality. The objective was to determine the prevalence of pulmonary hypertension among ELBW infants by screening echocardiography and evaluate subsequent out...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Right ventricular function in infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study.
Premature birth and bronchopulmonary dysplasia (BPD) are risk factors for the development of echocardiographic signs of pulmonary hypertension (PH) and are associated with changes in cardiac structure and function. It is unclear whether this association persists beyond early infancy. The aims of this study are to prosp...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
CRIB scores as a tool for assessing risk for the development of pulmonary hypertension in extremely preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Bronchopulmonary dysplasia (BPD) increases the risk for developing pulmonary hypertension (PH). However, the risk factors associated with BPD-associated PH remain unclear. Our primary aim was to determine perinatal risk factors associated with the development of PH in infants with BPD. ## STUDY DESIGN We r...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.
## OBJECTIVE To identify the association between birth weight (BW)-for-gestational age (GA) and pulmonary hypertension (PHTN) at 36 weeks in infants with moderate-severe bronchopulmonary dysplasia (BPD). ## STUDY DESIGN In this retrospective cohort study, we followed 138 premature infants (≤ 28 weeks) with moderate and...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia.
## BACKGROUND Bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) is a well-known complication of prematurity; however, the additional impact of a left-to-right interatrial shunt on this condition remains poorly understood. The aim of the present study was to identify the significance of atrial left...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Pulmonary hypertension (PH) is a known complication of bronchopulmonary dysplasia (BPD). This study aimed to determine the utility of serial N-Terminal pro-Brain Natriuretic Peptide (NTproBNP) levels in the screening of BPD associated PH (BPD-PH) in preterm infants. ## STUDY DESIGN Infants with birth weigh...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.
## OBJECTIVE To assess whether mortality in patients with evolving bronchopulmonary dysplasia (BPD, defined as ⩾28 days of oxygen exposure with lung disease) is independently associated with pulmonary arterial hypertension (PAH) and surgery. ## STUDY DESIGN Single institution retrospective birth cohort of preterm infan...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Association of unit-wide oxygen saturation target on incidence of pulmonary hypertension in very low birthweight premature infants.
## OBJECTIVE Assess the effect of increasing pulse oximetry targets on incidence of pulmonary hypertension in very low birthweight premature infants. ## STUDY DESIGN Retrospective cohort study comparing pulmonary hypertension incidence among three cohorts of premature infants exposed to varying oxygen saturation target...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Pulmonary hypertension with bronchopulmonary dysplasia: Aichi cohort study.
## BACKGROUND The incidence of pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) has not been investigated in regional cohorts. The aim of this study was to clarify the incidence of PH associated with BPD in all very low birthweight infants (VLBWIs) born during the study period in Aichi Prefe...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.
## BACKGROUND Although abnormal pulmonary vascular structure and function in preterm infants with bronchopulmonary dysplasia may predispose infants to pulmonary artery hypertension, little is known about the characteristics and outcomes of bronchopulmonary dysplasia-associated pulmonary artery hypertension in the surfa...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia.
## BACKGROUND Despite the potential importance of pulmonary artery hypertension (PAH) in preterm infants with bronchopulmonary dysplasia (BPD), little is known about the risk factors for PAH. ## OBJECTIVES To investigate the risk factors for PAH in preterm infants with BPD. ## METHODS Infants diagnosed with BPD were as...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.
## OBJECTIVES Bronchopulmonary dysplasia (BPD) and the associated complication of pulmonary hypertension (PH) leads to increased mortality and a longer length of stay among survivors. Placental histopathology may give early clues of subsequent events. The objective was to evaluate the relationship of maternal vascular ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year.
## OBJECTIVES To assess the effect of pulmonary hypertension on neonatal intensive care unit mortality and hospital readmission through 1 year of corrected age in a large multicenter cohort of infants with severe bronchopulmonary dysplasia. ## STUDY DESIGN This was a multicenter, retrospective cohort study of 1677 infa...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study.
## OBJECTIVE This study aimed to determine neurodevelopmental outcomes of preterm infants born at <29 weeks' gestational age (GA) with bronchopulmonary dysplasia and pulmonary hypertension (BPD-PH) at 18 to 24 months' corrected age (CA). ## STUDY DESIGN In this retrospective cohort study, preterm infants born at <29 we...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia.
## HYPOTHESIS Premature infants with bronchopulmonary dysplasia (BPD) are at increased risk of secondary pulmonary hypertension (BPD-PH). Prior studies yielded mixed results on the utility of echocardiographic screening at 36 weeks post-menstrual age (PMA). We present our experience using echocardiographic screening at...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
## RATIONALE Pulmonary hypertension (PH) is associated with poor outcomes among preterm infants with bronchopulmonary dysplasia (BPD), but whether early signs of pulmonary vascular disease are associated with the subsequent development of BPD or PH at 36 weeks post-menstrual age (PMA) is unknown. ## OBJECTIVES To prosp...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Hemodynamic and clinical consequences of early versus delayed closure of patent ductus arteriosus in extremely low birth weight infants.
## OBJECTIVES To describe changes in hemodynamics, respiratory support, and growth associated with transcatheter PDA closure (TCPC) in ELBW infants, stratified by postnatal age at treatment. ## STUDY DESIGN This is an observational study of ELBW infants who underwent TCPC at ≤4 weeks (Group-1; n = 34), 4-8 weeks (Group...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
## OBJECTIVE Extremely low gestational age newborns (ELGANs) represent an especially vulnerable population. Herein, we aimed to determine incidence and severity of pulmonary hypertension associated with bronchopulmonary dysplasia (BPD-PH) in extremely immature ELGANs (gestational age: 23 ## METHODS In this prospective ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE To investigate factors associated with development of early and late pulmonary hypertension (E/LPH) in preterm infants with bronchopulmonary dysplasia (BPD). ## STUDY DESIGN A retrospective case-control observational study of preterm infants with BPD admitted to a level IV referral neonatal intensive care ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation.
## OBJECTIVE The goal of this study was to delineate the epidemiology of echocardiographically diagnosed pulmonary hypertension (PH) in extremely low birth weight (ELBW) infants with bronchopulmonary dysplasia (BPD) requiring prolonged positive pressure ventilation (PPV), and to determine the independent relationship b...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia.
## AIM To test the hypothesis that there are single-nucleotide polymorphisms (SNPs) in genes of the l-arginine/nitric oxide pathway associated with pulmonary hypertension (PH) in neonates with bronchopulmonary dysplasia (BPD). ## METHODS Neonates with BPD were enrolled (n = 140) and clinical characteristics compared be...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Early characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit.
## BACKGROUND Approximately 8-23% of premature infants develop pulmonary hypertension (PH), and this diagnosis confers a higher possibility of mortality. As a result, professional societies recommend PH screening in premature infants. However, the risk factors for and the outcomes of PH may differ depending on the timi...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Pulmonary hypertension (PH) is a severe cardiovascular complication of bronchopulmonary dysplasia (BPD) that contributes to the high mortality rates for preterm infants. The objective of this study is to establish a prediction model of BPD-associated PH (BPD-PH) by integrating multiple predictive factors f...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Pulmonary hypertension in preterm infants: results of a prospective screening program.
## OBJECTIVE Determine prevalence and associations with pulmonary hypertension (PH) in preterm infants. ## STUDY DESIGN Prospective institutional echocardiographic PH screening at 36 to 38 weeks' corrected gestational age (GA) for infants born <32 weeks' GA who had bronchopulmonary dysplasia (BPD; group BPD), and infan...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Hipertensión pulmonar estimada por ecocardiografía en prematuros con displasia broncopulmonar: frecuencia, evolución y factores de riesgo.
## Trasfondo: La hipertensión pulmonar (HP) es una complicación evolutiva de los recién nacidos prematuros (RNPT) con displasia broncopulmonar (DBP). En nuestro medio, disponemos de escasa información epidemiológica sobre la HP asociada a DBP. Objetivos: Nuestro objetivo primario fue definir la frecuencia de HP asociad...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Any PDA
Risk Factors of Pulmonary Hypertension in Preterm Infants with Chronic Lung Disease.
## Purpose: Pulmonary hypertension (PH) is known as a major risk factor for preterm infants deaths, and associated with low gestational age, low birth weight, longer duration of oxygen therapy, low Apgar scores, and oligohydramnios. The aim of this study was to determine the risk factors for PH in preterm infants with ...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
Rationale: Extremely preterm infants with evolving bronchopulmonary dysplasia (BPD) are at risk for development of BPD-associated pulmonary hypertension (BPD-PH). A patent ductus arteriosus (PDA) shunt may be a modifiable risk factor for BPD-PH development. Objective: To determine whether the presence and duration of d...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
## BACKGROUND The aim of the study was to determine whether prolonged exposure to a moderate/large patent ductus arteriosus left-to-right shunt (PDA) increases the risk of late (beyond 36 weeks) pulmonary hypertension (BPD-PH) and pulmonary vascular disease (BPD-PVD) during the neonatal hospitalization in preterm infan...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children.
## INTRODUCTION Infants with bronchopulmonary dysplasia (BPD) are at high risk of developing cardiovascular sequelae in the form of pulmonary hypertension (PH) which significantly increases morbidity and mortality. The aim of this study was to evaluate the incidence of BPD, to identify characteristics associated with B...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## BACKGROUND AND OBJECTIVES With the increasing survival of preterm infants, pulmonary hypertension (PH) related to bronchopulmonary dysplasia (BPD) has become an important complication. The aim of this study was to investigate the characteristics and outcome of PH in preterm infants with BPD and to identify the risk ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation.
## OBJECTIVES Pulmonary hypertension (PH) is a complication of bronchopulmonary dysplasia (BPD) and associated with increased mortality and morbidity. Our aim was to identify, in infants with BPD, the effect of PH on health-care utilisation and health related cost of care. ## METHODS An electronic data recording system...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Oxygen requirement as a screening tool for the detection of late pulmonary hypertension in extremely low birth weight infants.
## BACKGROUND Many extremely low birth weight infants develop pulmonary hypertension late in their clinical course, and over 60% go undetected by early screening echocardiography. At present, no standardised screening protocol exists for detecting late pulmonary hypertension in extremely low birth weight infants. We as...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Prospective analysis of pulmonary hypertension in extremely low birth weight infants.
## OBJECTIVES Pulmonary hypertension is associated with bronchopulmonary dysplasia in extremely low birth weight (ELBW) infants and contributes to morbidity and mortality. The objective was to determine the prevalence of pulmonary hypertension among ELBW infants by screening echocardiography and evaluate subsequent out...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Right ventricular function in infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study.
Premature birth and bronchopulmonary dysplasia (BPD) are risk factors for the development of echocardiographic signs of pulmonary hypertension (PH) and are associated with changes in cardiac structure and function. It is unclear whether this association persists beyond early infancy. The aims of this study are to prosp...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
CRIB scores as a tool for assessing risk for the development of pulmonary hypertension in extremely preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Bronchopulmonary dysplasia (BPD) increases the risk for developing pulmonary hypertension (PH). However, the risk factors associated with BPD-associated PH remain unclear. Our primary aim was to determine perinatal risk factors associated with the development of PH in infants with BPD. ## STUDY DESIGN We r...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.
## OBJECTIVE To identify the association between birth weight (BW)-for-gestational age (GA) and pulmonary hypertension (PHTN) at 36 weeks in infants with moderate-severe bronchopulmonary dysplasia (BPD). ## STUDY DESIGN In this retrospective cohort study, we followed 138 premature infants (≤ 28 weeks) with moderate and...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia.
## BACKGROUND Bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) is a well-known complication of prematurity; however, the additional impact of a left-to-right interatrial shunt on this condition remains poorly understood. The aim of the present study was to identify the significance of atrial left...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Pulmonary hypertension (PH) is a known complication of bronchopulmonary dysplasia (BPD). This study aimed to determine the utility of serial N-Terminal pro-Brain Natriuretic Peptide (NTproBNP) levels in the screening of BPD associated PH (BPD-PH) in preterm infants. ## STUDY DESIGN Infants with birth weigh...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.
## OBJECTIVE To assess whether mortality in patients with evolving bronchopulmonary dysplasia (BPD, defined as ⩾28 days of oxygen exposure with lung disease) is independently associated with pulmonary arterial hypertension (PAH) and surgery. ## STUDY DESIGN Single institution retrospective birth cohort of preterm infan...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Association of unit-wide oxygen saturation target on incidence of pulmonary hypertension in very low birthweight premature infants.
## OBJECTIVE Assess the effect of increasing pulse oximetry targets on incidence of pulmonary hypertension in very low birthweight premature infants. ## STUDY DESIGN Retrospective cohort study comparing pulmonary hypertension incidence among three cohorts of premature infants exposed to varying oxygen saturation target...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Pulmonary hypertension with bronchopulmonary dysplasia: Aichi cohort study.
## BACKGROUND The incidence of pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) has not been investigated in regional cohorts. The aim of this study was to clarify the incidence of PH associated with BPD in all very low birthweight infants (VLBWIs) born during the study period in Aichi Prefe...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.
## BACKGROUND Although abnormal pulmonary vascular structure and function in preterm infants with bronchopulmonary dysplasia may predispose infants to pulmonary artery hypertension, little is known about the characteristics and outcomes of bronchopulmonary dysplasia-associated pulmonary artery hypertension in the surfa...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia.
## BACKGROUND Despite the potential importance of pulmonary artery hypertension (PAH) in preterm infants with bronchopulmonary dysplasia (BPD), little is known about the risk factors for PAH. ## OBJECTIVES To investigate the risk factors for PAH in preterm infants with BPD. ## METHODS Infants diagnosed with BPD were as...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.
## OBJECTIVES Bronchopulmonary dysplasia (BPD) and the associated complication of pulmonary hypertension (PH) leads to increased mortality and a longer length of stay among survivors. Placental histopathology may give early clues of subsequent events. The objective was to evaluate the relationship of maternal vascular ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year.
## OBJECTIVES To assess the effect of pulmonary hypertension on neonatal intensive care unit mortality and hospital readmission through 1 year of corrected age in a large multicenter cohort of infants with severe bronchopulmonary dysplasia. ## STUDY DESIGN This was a multicenter, retrospective cohort study of 1677 infa...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Neurodevelopmental Outcomes of Preterm Infants Born <29 Weeks with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Multicenter Study.
## OBJECTIVE This study aimed to determine neurodevelopmental outcomes of preterm infants born at <29 weeks' gestational age (GA) with bronchopulmonary dysplasia and pulmonary hypertension (BPD-PH) at 18 to 24 months' corrected age (CA). ## STUDY DESIGN In this retrospective cohort study, preterm infants born at <29 we...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia.
## HYPOTHESIS Premature infants with bronchopulmonary dysplasia (BPD) are at increased risk of secondary pulmonary hypertension (BPD-PH). Prior studies yielded mixed results on the utility of echocardiographic screening at 36 weeks post-menstrual age (PMA). We present our experience using echocardiographic screening at...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
## RATIONALE Pulmonary hypertension (PH) is associated with poor outcomes among preterm infants with bronchopulmonary dysplasia (BPD), but whether early signs of pulmonary vascular disease are associated with the subsequent development of BPD or PH at 36 weeks post-menstrual age (PMA) is unknown. ## OBJECTIVES To prosp...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Hemodynamic and clinical consequences of early versus delayed closure of patent ductus arteriosus in extremely low birth weight infants.
## OBJECTIVES To describe changes in hemodynamics, respiratory support, and growth associated with transcatheter PDA closure (TCPC) in ELBW infants, stratified by postnatal age at treatment. ## STUDY DESIGN This is an observational study of ELBW infants who underwent TCPC at ≤4 weeks (Group-1; n = 34), 4-8 weeks (Group...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
## OBJECTIVE Extremely low gestational age newborns (ELGANs) represent an especially vulnerable population. Herein, we aimed to determine incidence and severity of pulmonary hypertension associated with bronchopulmonary dysplasia (BPD-PH) in extremely immature ELGANs (gestational age: 23 ## METHODS In this prospective ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Factors associated with development of early and late pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE To investigate factors associated with development of early and late pulmonary hypertension (E/LPH) in preterm infants with bronchopulmonary dysplasia (BPD). ## STUDY DESIGN A retrospective case-control observational study of preterm infants with BPD admitted to a level IV referral neonatal intensive care ...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation.
## OBJECTIVE The goal of this study was to delineate the epidemiology of echocardiographically diagnosed pulmonary hypertension (PH) in extremely low birth weight (ELBW) infants with bronchopulmonary dysplasia (BPD) requiring prolonged positive pressure ventilation (PPV), and to determine the independent relationship b...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Arginase I gene single-nucleotide polymorphism is associated with decreased risk of pulmonary hypertension in bronchopulmonary dysplasia.
## AIM To test the hypothesis that there are single-nucleotide polymorphisms (SNPs) in genes of the l-arginine/nitric oxide pathway associated with pulmonary hypertension (PH) in neonates with bronchopulmonary dysplasia (BPD). ## METHODS Neonates with BPD were enrolled (n = 140) and clinical characteristics compared be...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Early characteristics of infants with pulmonary hypertension in a referral neonatal intensive care unit.
## BACKGROUND Approximately 8-23% of premature infants develop pulmonary hypertension (PH), and this diagnosis confers a higher possibility of mortality. As a result, professional societies recommend PH screening in premature infants. However, the risk factors for and the outcomes of PH may differ depending on the timi...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Pulmonary hypertension (PH) is a severe cardiovascular complication of bronchopulmonary dysplasia (BPD) that contributes to the high mortality rates for preterm infants. The objective of this study is to establish a prediction model of BPD-associated PH (BPD-PH) by integrating multiple predictive factors f...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Pulmonary hypertension in preterm infants: results of a prospective screening program.
## OBJECTIVE Determine prevalence and associations with pulmonary hypertension (PH) in preterm infants. ## STUDY DESIGN Prospective institutional echocardiographic PH screening at 36 to 38 weeks' corrected gestational age (GA) for infants born <32 weeks' GA who had bronchopulmonary dysplasia (BPD; group BPD), and infan...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Hipertensión pulmonar estimada por ecocardiografía en prematuros con displasia broncopulmonar: frecuencia, evolución y factores de riesgo.
## Trasfondo: La hipertensión pulmonar (HP) es una complicación evolutiva de los recién nacidos prematuros (RNPT) con displasia broncopulmonar (DBP). En nuestro medio, disponemos de escasa información epidemiológica sobre la HP asociada a DBP. Objetivos: Nuestro objetivo primario fue definir la frecuencia de HP asociad...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Patent Ductus Arteriosus (PDA) - Hemodynamically significant PDA
Risk Factors of Pulmonary Hypertension in Preterm Infants with Chronic Lung Disease.
## Purpose: Pulmonary hypertension (PH) is known as a major risk factor for preterm infants deaths, and associated with low gestational age, low birth weight, longer duration of oxygen therapy, low Apgar scores, and oligohydramnios. The aim of this study was to determine the risk factors for PH in preterm infants with ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
Rationale: Extremely preterm infants with evolving bronchopulmonary dysplasia (BPD) are at risk for development of BPD-associated pulmonary hypertension (BPD-PH). A patent ductus arteriosus (PDA) shunt may be a modifiable risk factor for BPD-PH development. Objective: To determine whether the presence and duration of d...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
## BACKGROUND The aim of the study was to determine whether prolonged exposure to a moderate/large patent ductus arteriosus left-to-right shunt (PDA) increases the risk of late (beyond 36 weeks) pulmonary hypertension (BPD-PH) and pulmonary vascular disease (BPD-PVD) during the neonatal hospitalization in preterm infan...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children.
## INTRODUCTION Infants with bronchopulmonary dysplasia (BPD) are at high risk of developing cardiovascular sequelae in the form of pulmonary hypertension (PH) which significantly increases morbidity and mortality. The aim of this study was to evaluate the incidence of BPD, to identify characteristics associated with B...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## BACKGROUND AND OBJECTIVES With the increasing survival of preterm infants, pulmonary hypertension (PH) related to bronchopulmonary dysplasia (BPD) has become an important complication. The aim of this study was to investigate the characteristics and outcome of PH in preterm infants with BPD and to identify the risk ...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Pulmonary hypertension in infants with bronchopulmonary dysplasia: risk factors, mortality and duration of hospitalisation.
## OBJECTIVES Pulmonary hypertension (PH) is a complication of bronchopulmonary dysplasia (BPD) and associated with increased mortality and morbidity. Our aim was to identify, in infants with BPD, the effect of PH on health-care utilisation and health related cost of care. ## METHODS An electronic data recording system...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Oxygen requirement as a screening tool for the detection of late pulmonary hypertension in extremely low birth weight infants.
## BACKGROUND Many extremely low birth weight infants develop pulmonary hypertension late in their clinical course, and over 60% go undetected by early screening echocardiography. At present, no standardised screening protocol exists for detecting late pulmonary hypertension in extremely low birth weight infants. We as...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Prospective analysis of pulmonary hypertension in extremely low birth weight infants.
## OBJECTIVES Pulmonary hypertension is associated with bronchopulmonary dysplasia in extremely low birth weight (ELBW) infants and contributes to morbidity and mortality. The objective was to determine the prevalence of pulmonary hypertension among ELBW infants by screening echocardiography and evaluate subsequent out...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Right ventricular function in infants with bronchopulmonary dysplasia and pulmonary hypertension: a pilot study.
Premature birth and bronchopulmonary dysplasia (BPD) are risk factors for the development of echocardiographic signs of pulmonary hypertension (PH) and are associated with changes in cardiac structure and function. It is unclear whether this association persists beyond early infancy. The aims of this study are to prosp...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
CRIB scores as a tool for assessing risk for the development of pulmonary hypertension in extremely preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Bronchopulmonary dysplasia (BPD) increases the risk for developing pulmonary hypertension (PH). However, the risk factors associated with BPD-associated PH remain unclear. Our primary aim was to determine perinatal risk factors associated with the development of PH in infants with BPD. ## STUDY DESIGN We r...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.
## OBJECTIVE To identify the association between birth weight (BW)-for-gestational age (GA) and pulmonary hypertension (PHTN) at 36 weeks in infants with moderate-severe bronchopulmonary dysplasia (BPD). ## STUDY DESIGN In this retrospective cohort study, we followed 138 premature infants (≤ 28 weeks) with moderate and...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia.
## BACKGROUND Bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension (PH) is a well-known complication of prematurity; however, the additional impact of a left-to-right interatrial shunt on this condition remains poorly understood. The aim of the present study was to identify the significance of atrial left...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
## OBJECTIVE Pulmonary hypertension (PH) is a known complication of bronchopulmonary dysplasia (BPD). This study aimed to determine the utility of serial N-Terminal pro-Brain Natriuretic Peptide (NTproBNP) levels in the screening of BPD associated PH (BPD-PH) in preterm infants. ## STUDY DESIGN Infants with birth weigh...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Mortality among infants with evolving bronchopulmonary dysplasia increases with major surgery and with pulmonary hypertension.
## OBJECTIVE To assess whether mortality in patients with evolving bronchopulmonary dysplasia (BPD, defined as ⩾28 days of oxygen exposure with lung disease) is independently associated with pulmonary arterial hypertension (PAH) and surgery. ## STUDY DESIGN Single institution retrospective birth cohort of preterm infan...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Association of unit-wide oxygen saturation target on incidence of pulmonary hypertension in very low birthweight premature infants.
## OBJECTIVE Assess the effect of increasing pulse oximetry targets on incidence of pulmonary hypertension in very low birthweight premature infants. ## STUDY DESIGN Retrospective cohort study comparing pulmonary hypertension incidence among three cohorts of premature infants exposed to varying oxygen saturation target...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Pulmonary hypertension with bronchopulmonary dysplasia: Aichi cohort study.
## BACKGROUND The incidence of pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) has not been investigated in regional cohorts. The aim of this study was to clarify the incidence of PH associated with BPD in all very low birthweight infants (VLBWIs) born during the study period in Aichi Prefe...
True
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.
## BACKGROUND Although abnormal pulmonary vascular structure and function in preterm infants with bronchopulmonary dysplasia may predispose infants to pulmonary artery hypertension, little is known about the characteristics and outcomes of bronchopulmonary dysplasia-associated pulmonary artery hypertension in the surfa...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia.
## BACKGROUND Despite the potential importance of pulmonary artery hypertension (PAH) in preterm infants with bronchopulmonary dysplasia (BPD), little is known about the risk factors for PAH. ## OBJECTIVES To investigate the risk factors for PAH in preterm infants with BPD. ## METHODS Infants diagnosed with BPD were as...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
Bronchopulmonary dysplasia-associated pulmonary hypertension: clues from placental pathology.
## OBJECTIVES Bronchopulmonary dysplasia (BPD) and the associated complication of pulmonary hypertension (PH) leads to increased mortality and a longer length of stay among survivors. Placental histopathology may give early clues of subsequent events. The objective was to evaluate the relationship of maternal vascular ...
False
38015504
Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
Is patent ductus arteriosus (PDA) associated with a higher risk of developing bronchopulmonary dysplasia–associated pulmonary hypertension (BPD-PH) among very and extremely preterm infants?
Two reviewers (E.V. and E.v.W.-K.) extracted data from relevant studies, and another reviewer (M.J.H.) checked data extraction for accuracy and completeness. Discrepancies were resolved by consulting the primary report. The outcome considered in meta-analysis was BPD-PH, defined by any echocardiographic criteria as lon...
Bayesian Model-Averaged Meta-Analysis of the Association of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH) With Surgically Ligated or Catheter Occluded Patent Ductus Arteriosus (PDA) - PDA-exposed/total
The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year.
## OBJECTIVES To assess the effect of pulmonary hypertension on neonatal intensive care unit mortality and hospital readmission through 1 year of corrected age in a large multicenter cohort of infants with severe bronchopulmonary dysplasia. ## STUDY DESIGN This was a multicenter, retrospective cohort study of 1677 infa...
True